Page 62 - 2020_02-Haematologica-web

R. Vilar et al.
110.Pedersen A, Stanne TM, Redfors P, et al. Fibrinogen concentrations predict long-term cognitive outcome in young ischemic stroke patients. Res Pract Thromb Haemost. 2018;2(2):339-346.
111. Bijak M, Olejnik A, Rokita B, et al. Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients. J Cell Mol Med. 2019;23(5):3476-3482.
112. Negron O, Flick MJ. Does fibrinogen serve the host or the microbe in Staphylococcus infection? Curr Opin Hematol. 2019;26(5):343-348.
113. Landers CT, Tung HY, Knight JM, et al. Selective fibrinogen cleavage by diverse pro- teinases initiates innate allergic and antifun- gal immunity through CD11b. J Biol Chem. 2019;294(22):8834-8847.
114.Liesenborghs L, Meyers S, Lox M, et al. Staphylococcus aureus endocarditis: distinct mechanisms of bacterial adhesion to dam- aged and inflamed heart valves. Eur Heart J. 2019;40(39):3248-3259.
115.Watve MG, Tickoo R, Jog MM, et al. How many antibiotics are produced by the genus Streptomyces? Arch Microbiol. 2001;176(5): 386-390.
116.Yike I. Fungal proteases and their patho- physiological effects. Mycopathologia. 2011;171(5):299-323.
117. Barrera V, Skorokhod OA, Baci D, et al. Host fibrinogen stably bound to hemozoin rapid- ly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action. Blood. 2011;117(21):5674- 5682.
118.Ling GS, Bennett J, Woollard KJ, et al. Integrin CD11b positively regulates TLR4-
induced signalling pathways in dendritic cells but not in macrophages. Nat Commun. 2014;5:3039.
119. Colvin RB, Mosesson MW, Dvorak HF. Delayed-type hypersensitivity skin reac- tions in congenital afibrinogenemia lack fib- rin deposition and induration. J Clin Invest. 1979;63(6):1302-1306.
127.Undas A, Ariens RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic dis- eases. Arterioscler Thromb Vasc Biol. 2011;31(12):e88-e99.
120. 121.
122.
123.
124.
Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121(6):2111-2117. Morange PE, Alessi MC. Thrombosis in cen- tral obesity and metabolic syndrome: mech- anisms and epidemiology. Thromb Haemost. 2013;110(4):669-680.
Stalls CM, Triplette MA, Viera AJ, et al. The association between body mass index and coronary artery disease severity: a compari- son of black and white patients. Am Heart J. 2014;167(4):514-520.
Avellone G, di Garbo V, Cordova R, et al. Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-depen- dent diabetic patients. Metabolism. 1997;46(8):930-934.
Handley DA, Hughes TE. Pharmacological approaches and strategies for therapeutic modulation of fibrinogen. Thromb Res. 1997;87(1):1-36.
129.Flick MJ, Du X, Witte DP, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest. 2004;113(11):1596-1606.
130. Glenner GG. Amyloid deposits and amyloi- dosis. The beta-fibrilloses (first of two parts). N Engl J Med. 1980;302(23):1283-1292.
131.Hol PR, Snel FW, Niewold TA, et al. Amyloid-enhancing factor (AEF) in the pathogenesis of AA-amyloidosis in the ham- ster. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;52(3):273-281.
125. De Feo P, Volpi E, Lucidi P, et al. Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes. 1993;42(7):995- 1002.
126.De Feo P, Gaisano MG, Haymond MW. Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest. 1991;88(3):833-840.
133. Uemichi T, Liepnieks JJ, Yamada T, et al. A frame shift mutation in the fibrinogen A alpha chain gene in a kindred with renal amyloidosis. Blood. 1996;87(10):4197- 4203.
128.
Kopec AK, Abrahams SR, Thornton S, et al. Thrombin promotes diet-induced obesity through fibrin-driven inflammation. J Clin Invest. 2017;127(8):3152-3166.
132.
Page MJ, Thomson GJA, Nunes JM, et al. Serum amyloid A binds to fibrin(ogen), pro- moting fibrin amyloid formation. Sci Rep. 2019;9(1):3102.
134.
Stangou AJ, Banner NR, Hendry BM, et al. Hereditary fibrinogen A alpha-chain amyloi- dosis: phenotypic characterization of a sys- temic disease and the role of liver transplan- tation. Blood. 2010;115(15):2998-3007.
135. Picken MM. Fibrinogen amyloidosis: the clot thickens! Blood. 2010;115(15):2985- 2986.
296
haematologica | 2020; 105(2)